Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

The Specials Laboratory

The Specials lab manufactures and supplies Specials drug tariff and non-tariffed unlicensed medicines (commonly known as ‘specials’) to community Pharmacists, Doctors, Vet Surgeons and Hospitals – within 24 hours. We provide hospitals with a space and time saving over labelling service, which involves the bespoke design and labelling of medicines. Once set-up, we store your over labelled products and deliver what you want, when you want – again, within 24 hours. And for hospitals, we also offer investigational medicinal product (IMP) manufacturing from our MHRA-licensed sites so we can meet the supply needs of hospital-based clinical trials.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

The Specials Laboratory
Unit 1 Regents Drive Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
01661 831 811
Contact The Specials Laboratory
Website

 Latest Content from PMHub 

Behind the scenes: why we created ‘The participation equation’

White Papers and Resources | November 28, 2025 | Cuttsy + Cuttsy

Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

White Papers and Resources | November 28, 2025 | Inizio

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

Press Releases | November 27, 2025 | Cuttsy + Cuttsy

Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

Does real-world use of AI in systematic literature reviews result in time and cost savings?

White Papers and Resources | November 27, 2025 | Amiculum

By Manca Povsic and Emma Griffiths

How DataGateway unified oncology data for real-world insights & market intelligence

White Papers and Resources | November 26, 2025 | Inizio

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Press Releases | November 26, 2025 | Inizio

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

White Papers and Resources | November 26, 2025 | Inizio

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Is Joint Clinical Assessment (JCA) appropriate for assessing the broader value of vaccines?

White Papers and Resources | November 21, 2025 | Amiculum

By Emily Morton-West

The Future of MSL Training – How Digital Technologies Are Shaping Success

Press Releases | November 20, 2025 | Impetus Digital

Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, track performance, and achieve cost-effective, consistent training for global teams.

Women Leaders Rewriting the Protocols of Rare Disease Care

Press Releases | November 20, 2025 | Medscape Education

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...